|
Can a dataset be "overdispersed" if I'm not using a model with assumptions on normality?
|
|
2
|
2336
|
July 28, 2019
|
|
Bayesian Power: No Unobservables
|
|
6
|
9115
|
July 8, 2019
|
|
Sample size for a study to validate a predictive model
|
|
1
|
3335
|
May 1, 2019
|
|
What about this weird 2 arm design (Lancet article)
|
|
8
|
3820
|
April 8, 2019
|
|
Sample size in mixed model study (exploratory prognostic factor study)
|
|
8
|
4770
|
March 31, 2019
|
|
Cluster-Randomized Trial: Design Question
|
|
5
|
5240
|
March 29, 2019
|
|
"Voracious demand for data" of pure probabilistic reasoning
|
|
1
|
2824
|
March 15, 2019
|
|
Cumulative toxicity endpoint opinion
|
|
3
|
4464
|
March 5, 2019
|
|
How to use p-values when sample sizes are not fixed
|
|
5
|
3792
|
March 1, 2019
|
|
Precision as the goal for sample size estimation
|
|
12
|
10657
|
January 28, 2019
|
|
Assigning time zero in an observational comparative effectiveness study
|
|
2
|
4390
|
January 22, 2019
|
|
Can this be a possible statistical solution for a mid-trial realization?
|
|
8
|
3053
|
November 22, 2018
|
|
Protocol deviation and its impact on stat analysis
|
|
8
|
3809
|
October 21, 2018
|
|
Propensity score methods vs Penalized regression
|
|
22
|
15123
|
October 9, 2018
|
|
Health care experiences that altered your perspective on biostatistical ethics?
|
|
1
|
2487
|
September 30, 2018
|
|
The role of simulation in developing analysis plans
|
|
7
|
5479
|
September 30, 2018
|
|
How might we use Bayesian priors in observational studies of drug safety?
|
|
1
|
2327
|
September 15, 2018
|
|
What is an adequate `pilot` study leading to a stepped-wedge cluster randomized trial
|
|
0
|
2455
|
September 10, 2018
|
|
Estimating recruitment rate based on feasibility studies
|
|
6
|
3851
|
September 6, 2018
|